Image 1
Irbesartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 0093-8232
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Irbesartan And Hydrochlorothiazide (NDC 0093-8232). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Irbesartan And Hydrochlorothiazide Tablets Usp 300 mg/12.5 mg 30s Label (Image 10)
This is a medication for Hydrochlorothiazide Tablets USP in 300 mg/12.5 mg strength with NDC number 0093-8232-56. It also contains Irbesartan and comes in a pack of 30 tablets. The medication should be kept out of the reach of children. The remaining text appears to be manufacturing or labeling information.*
Image 2
Image 3
Image 4
Image 5
Image 6
Image 7
This appears to be a table displaying the recommended doses of the medication Irbesartan (in milligrams per day) at various increments (12, 150, 300, 450, 600, and 750).*
Image 8
This text is a table showing different doses of Irbesartan (an angiotensin II receptor antagonist used to treat high blood pressure) ranging from 150mg/day to 900mg/day.*
Image 9
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
